BPC-157/TB-500

BPC-157 + TB500

$80.00 USD

QTY (x10)

All products are intended for use by licensed physicians, medical practitioners, and healthcare professionals.

CERTIFICATE OF ANALYSIS

Third-party tested for purity, identity, and quantity.

Overview:

BPC-157 (10mg) / TB-500 (10mg) is a combination of two synthetic research peptides commonly discussed in the context of tissue-response, structural remodeling, and cellular-migration models. BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids and modeled after a peptide sequence associated with gastric tissue. TB-500 is commonly identified as the N-acetylated 17–23 fragment of thymosin beta-4, a naturally occurring peptide involved in actin regulation and cellular movement.

Much of the scientific interest around this combination comes from the different but potentially complementary biological pathways associated with each peptide. BPC-157 has been studied in experimental models involving nitric oxide signaling, vascular response, angiogenesis-related pathways, fibroblast activity, and extracellular matrix remodeling. TB-500 is generally discussed in relation to thymosin beta-4 biology, including actin regulation, cell migration, endothelial activity, and tissue-remodeling models.

BPC-157 / TB-500 has not been established as a combined therapeutic product, and the scientific discussion around the combination is largely extrapolated from research on each peptide individually. The available evidence is primarily laboratory, animal, analytical, and preclinical in nature. These areas remain investigational and should be interpreted within the limits of the current research.

Mechanism Overview:

BPC-157 / TB-500 has been discussed for potential interaction with several biological pathways related to tissue-response signaling and cellular remodeling. BPC-157 has been investigated for nitric oxide modulation, VEGF-related angiogenesis, endothelial function, fibroblast activity, and extracellular matrix remodeling. TB-500 has been investigated in relation to thymosin beta-4-associated pathways, including actin binding, cell migration, angiogenesis-related signaling, and endothelial activity. While these pathways are biologically relevant in experimental models, they are not equivalent to established clinical outcomes in humans.